Toddaculin, a natural coumarin from Toddalia asiatica, induces differentiation and apoptosis in U-937 leukemic cells. 2012

Ramiro Vázquez, and María E Riveiro, and Mónica Vermeulen, and Carolina Mondillo, and Philip H Coombes, and Neil R Crouch, and Fathima Ismail, and Dulcie A Mulholland, and Alberto Baldi, and Carina Shayo, and Carlos Davio
Laboratorio de Patología y Farmacología Molecular, Instituto de Biología y Medicina Experimental, CONICET, Vuelta de Obligado 2490, C1428ADN, Buenos Aires, Argentina. ramirobioq@hotmail.com

Chemotherapeutics represent the main approach for the treatment of leukemia. However, the occurrence of adverse side effects and the complete lack of effectiveness in some cases make it necessary to develop new drugs. As part of our screening program to evaluate the potential chemotherapeutic effect of natural coumarins, we investigated the anti-leukemic activities of a series of six prenylated coumarins isolated from the stem bark of Toddalia asiatica (Rutaceae). Among these, 6-(3-methyl-2-butenyl)-5,7-dimethoxycoumarin (toddaculin) displayed the most potent cytotoxic and anti-proliferative effects in U-937 cells. To determine whether these effects resulted from induction of cell death or differentiation, we further evaluated the expression of several apoptosis and maturation markers. Interestingly, while toddaculin at 250 μM was able to induce apoptosis in U-937 cells, involving decreased phosphorylation levels of ERK and Akt, 50 μM toddaculin exerted differentiating effects, inducing both the capacity of U-937 cells to reduce NBT and the expression of differentiation markers CD88 and CD11b, but no change in p-Akt or p-ERK levels. Taken together, these findings indicate that toddaculin displays a dual effect as a cell differentiating agent and apoptosis inducer in U-937 cells, suggesting it may serve as a pharmacological prototype for the development of novel anti-leukemic agents.

UI MeSH Term Description Entries
D007938 Leukemia A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006) Leucocythaemia,Leucocythemia,Leucocythaemias,Leucocythemias,Leukemias
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D003374 Coumarins Synthetic or naturally occurring substances related to coumarin, the delta-lactone of coumarinic acid. 1,2-Benzopyrone Derivatives,1,2-Benzopyrones,Coumarin Derivative,Coumarine,1,2-Benzo-Pyrones,Benzopyran-2-ones,Coumarin Derivatives,Coumarines,1,2 Benzo Pyrones,1,2 Benzopyrone Derivatives,1,2 Benzopyrones,Benzopyran 2 ones,Derivative, Coumarin,Derivatives, 1,2-Benzopyrone,Derivatives, Coumarin
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000972 Antineoplastic Agents, Phytogenic Agents obtained from higher plants that have demonstrable cytostatic or antineoplastic activity. Antineoplastics, Botanical,Antineoplastics, Phytogenic,Agents, Phytogenic Antineoplastic,Botanical Antineoplastics,Phytogenic Antineoplastic Agents,Phytogenic Antineoplastics
D015536 Down-Regulation A negative regulatory effect on physiological processes at the molecular, cellular, or systemic level. At the molecular level, the major regulatory sites include membrane receptors, genes (GENE EXPRESSION REGULATION), mRNAs (RNA, MESSENGER), and proteins. Receptor Down-Regulation,Down-Regulation (Physiology),Downregulation,Down Regulation,Down-Regulation, Receptor
D017209 Apoptosis A regulated cell death mechanism characterized by distinctive morphologic changes in the nucleus and cytoplasm, including the endonucleolytic cleavage of genomic DNA, at regularly spaced, internucleosomal sites, i.e., DNA FRAGMENTATION. It is genetically programmed and serves as a balance to mitosis in regulating the size of animal tissues and in mediating pathologic processes associated with tumor growth. Apoptosis, Extrinsic Pathway,Apoptosis, Intrinsic Pathway,Caspase-Dependent Apoptosis,Classic Apoptosis,Classical Apoptosis,Programmed Cell Death,Programmed Cell Death, Type I,Apoptoses, Extrinsic Pathway,Apoptoses, Intrinsic Pathway,Apoptosis, Caspase-Dependent,Apoptosis, Classic,Apoptosis, Classical,Caspase Dependent Apoptosis,Cell Death, Programmed,Classic Apoptoses,Extrinsic Pathway Apoptoses,Extrinsic Pathway Apoptosis,Intrinsic Pathway Apoptoses,Intrinsic Pathway Apoptosis
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D048049 Extracellular Signal-Regulated MAP Kinases A mitogen-activated protein kinase subfamily that is widely expressed and plays a role in regulation of MEIOSIS; MITOSIS; and post mitotic functions in differentiated cells. The extracellular signal regulated MAP kinases are regulated by a broad variety of CELL SURFACE RECEPTORS and can be activated by certain CARCINOGENS. ERK MAP Kinase,ERK MAP Kinases,Extracellular Signal-Regulated Kinase,Extracellular Signal-Regulated Kinases,Extracellular Signal-Regulated MAP Kinase,MAP Kinases, Extracellular Signal-Regulated,Extracellular Signal Regulated Kinase,Extracellular Signal Regulated Kinases,Extracellular Signal Regulated MAP Kinase,Extracellular Signal Regulated MAP Kinases,Kinase, ERK MAP,Kinase, Extracellular Signal-Regulated,Kinases, Extracellular Signal-Regulated,MAP Kinase, ERK,MAP Kinases, Extracellular Signal Regulated,Signal-Regulated Kinase, Extracellular

Related Publications

Ramiro Vázquez, and María E Riveiro, and Mónica Vermeulen, and Carolina Mondillo, and Philip H Coombes, and Neil R Crouch, and Fathima Ismail, and Dulcie A Mulholland, and Alberto Baldi, and Carina Shayo, and Carlos Davio
December 2000, Fitoterapia,
Ramiro Vázquez, and María E Riveiro, and Mónica Vermeulen, and Carolina Mondillo, and Philip H Coombes, and Neil R Crouch, and Fathima Ismail, and Dulcie A Mulholland, and Alberto Baldi, and Carina Shayo, and Carlos Davio
January 1998, Cancer chemotherapy and pharmacology,
Ramiro Vázquez, and María E Riveiro, and Mónica Vermeulen, and Carolina Mondillo, and Philip H Coombes, and Neil R Crouch, and Fathima Ismail, and Dulcie A Mulholland, and Alberto Baldi, and Carina Shayo, and Carlos Davio
January 2015, PloS one,
Ramiro Vázquez, and María E Riveiro, and Mónica Vermeulen, and Carolina Mondillo, and Philip H Coombes, and Neil R Crouch, and Fathima Ismail, and Dulcie A Mulholland, and Alberto Baldi, and Carina Shayo, and Carlos Davio
October 2014, Biochemical and biophysical research communications,
Ramiro Vázquez, and María E Riveiro, and Mónica Vermeulen, and Carolina Mondillo, and Philip H Coombes, and Neil R Crouch, and Fathima Ismail, and Dulcie A Mulholland, and Alberto Baldi, and Carina Shayo, and Carlos Davio
January 2018, Biological & pharmaceutical bulletin,
Ramiro Vázquez, and María E Riveiro, and Mónica Vermeulen, and Carolina Mondillo, and Philip H Coombes, and Neil R Crouch, and Fathima Ismail, and Dulcie A Mulholland, and Alberto Baldi, and Carina Shayo, and Carlos Davio
April 1994, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research,
Ramiro Vázquez, and María E Riveiro, and Mónica Vermeulen, and Carolina Mondillo, and Philip H Coombes, and Neil R Crouch, and Fathima Ismail, and Dulcie A Mulholland, and Alberto Baldi, and Carina Shayo, and Carlos Davio
April 2014, Journal of natural products,
Ramiro Vázquez, and María E Riveiro, and Mónica Vermeulen, and Carolina Mondillo, and Philip H Coombes, and Neil R Crouch, and Fathima Ismail, and Dulcie A Mulholland, and Alberto Baldi, and Carina Shayo, and Carlos Davio
February 1996, Blood,
Ramiro Vázquez, and María E Riveiro, and Mónica Vermeulen, and Carolina Mondillo, and Philip H Coombes, and Neil R Crouch, and Fathima Ismail, and Dulcie A Mulholland, and Alberto Baldi, and Carina Shayo, and Carlos Davio
January 2000, Tsitologiia,
Ramiro Vázquez, and María E Riveiro, and Mónica Vermeulen, and Carolina Mondillo, and Philip H Coombes, and Neil R Crouch, and Fathima Ismail, and Dulcie A Mulholland, and Alberto Baldi, and Carina Shayo, and Carlos Davio
January 2009, Iranian biomedical journal,
Copied contents to your clipboard!